Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Marketo, Inc. | 5,663,756 | reported | 25 Feb 2014 | tx 11+370,533−3,808,435 |
| OBALON THERAPEUTICS INC | 3,552,239 | reported | 23 Aug 2018 | tx 1+1,098,901 |
| CORGENTECH INC | 2,721,685 | reported | 17 Mar 2006 | tx 5+6,000 |
| Celladon Corp | 1,388,792 | reported | 18 Oct 2018 | tx 2−237,265 |
| Doximity, Inc. | 449,960 | reported | 02 Aug 2022 | tx 26+37,027,337−49,466,627 |
| GLAUKOS Corp | 37,406 | reported | 28 May 2026 | tx 90+2,891,485−6,446,598 |
| STAAR SURGICAL CO | 10,457 | reported | 01 Dec 2023 | tx 9+11,307 |
| AVEDRO INC | 3,005 | reported | 14 Jun 2019 | tx 9+2,676,946−2,640,627 |
| PMV Pharmaceuticals, Inc. | 2,816 | reported | 13 Jul 2021 | tx 15+6,595,774−7,011,988 |
| EPOCRATES INC | 0 | reported | 07 Feb 2011 | tx 14+2,398,434−3,350,092 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2026 | GRANT_AWARD | GLAUKOS Corp | 1,878 | 0.00 USD | |
| 28 May 2026 | GRANT_AWARD | GLAUKOS Corp | 2,987 | 0.00 USD | deriv |
| 14 May 2026 | EXERCISE | GLAUKOS Corp | 5,000 | 24.69 USD | |
| 14 May 2026 | SALE | GLAUKOS Corp | 5,000 | 140.76 USD | |
| 14 May 2026 | EXERCISE | GLAUKOS Corp | 5,000 | 24.69 USD | deriv |
| 11 May 2026 | EXERCISE | GLAUKOS Corp | 5,000 | 24.69 USD | |
| 11 May 2026 | SALE | GLAUKOS Corp | 5,000 | 135.00 USD | |
| 11 May 2026 | EXERCISE | GLAUKOS Corp | 5,000 | 24.69 USD | deriv |
| 02 Jan 2026 | GRANT_AWARD | GLAUKOS Corp | 623 | 0.00 USD | |
| 09 Dec 2025 | EXERCISE | GLAUKOS Corp | 5,000 | 24.69 USD | |
| 09 Dec 2025 | SALE | GLAUKOS Corp | 5,000 | 107.27 USD | |
| 09 Dec 2025 | EXERCISE | GLAUKOS Corp | 5,000 | 24.69 USD | deriv |
| 29 May 2025 | GRANT_AWARD | GLAUKOS Corp | 2,108 | 0.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | GLAUKOS Corp | 461 | 0.00 USD | |
| 29 May 2025 | GRANT_AWARD | GLAUKOS Corp | 3,149 | 0.00 USD | deriv |
| 20 Dec 2024 | SALE | GLAUKOS Corp | 10,000 | 150.28 USD | |
| 20 Dec 2024 | EXERCISE | GLAUKOS Corp | 10,000 | 32.00 USD | |
| 20 Dec 2024 | EXERCISE | GLAUKOS Corp | 10,000 | 0.00 USD | deriv |
| 11 Dec 2024 | EXERCISE | GLAUKOS Corp | 2,000 | 32.00 USD | |
| 11 Dec 2024 | SALE | GLAUKOS Corp | 2,000 | 144.01 USD | |
| 11 Dec 2024 | EXERCISE | GLAUKOS Corp | 2,000 | 0.00 USD | deriv |
| 09 Sept 2024 | EXERCISE | GLAUKOS Corp | 3,000 | 32.00 USD | |
| 09 Sept 2024 | SALE | GLAUKOS Corp | 1,000 | 130.00 USD | |
| 09 Sept 2024 | SALE | GLAUKOS Corp | 2,000 | 131.00 USD | |
| 09 Sept 2024 | EXERCISE | GLAUKOS Corp | 3,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 09 Aug 2018.